Fisetin shows potential as a nutritional senotherapeutic but lacks clinical evidence for chronic kidney disease
Fisetin shows potential for managing chronic kidney disease
This mini review explores the potential of Fisetin as a nutritional senotherapeutic for age-related diseases. The authors conclude that whil…
A natural compound called fisetin may help target age-related issues in the kidneys, though more clinical evidence is needed to confirm its …
Senolytics like dasatinib and quercetin show promise for improving skeletal parameters in osteoporosis models
Senolytics Show Potential for Improving Bone Health in Osteoporosis
This narrative review synthesizes preclinical and early clinical evidence regarding senolytics including dasatinib, quercetin, and fisetin f…
New research explores how senolytics like dasatinib and quercetin may reduce inflammation and improve bone health in patients with osteoporo…